October 16, 2020
“Zynerba Pharmaceuticals (ZYNE)… Turning to the rest of the Street, the bulls have it on this one. With 3 Buys and a lone Hold, the word on the Street is that ZYNE is a Strong Buy. At $13, the average… Continue Reading…
October 15, 2020
“Catalyst Biosciences (CBIO)… Other analysts don’t beg to differ. With 3 Buy ratings and no Holds or Sells, the word on the Street is that CBIO is a Strong Buy. At $19.33, the average price target implies 303% upside potential… Continue Reading…
October 9, 2020
“Mesa Air Group (MESA)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, MESA has a Strong Buy consensus rating. With the average price target… Continue Reading…
October 8, 2020
“Mesa Air Group (MESA)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, MESA has a Strong Buy consensus rating. With the average price target… Continue Reading…
October 7, 2020
“Lowe’s said Wednesday it will give $100 million more in bonuses to hourly employees, as strong demand for home improvement continues. It marks the sixth time the home improvement retailer has given additional pay to workers at its stores… With the… Continue Reading…
September 30, 2020
“Brickell Biotech (BBI)… Looking at the consensus breakdown, 2 Buys and no Holds or Sells have been published in the last three months. As a result, BBI gets a Moderate Buy consensus rating. The $5 average price target is identical… Continue Reading…
September 26, 2020
“NexTier Oilfield Solutions (NEX)… Similarly, the rest of the Street is getting onboard. 6 Buy ratings and 2 Hold assigned in the last three months add up to a Strong Buy analyst consensus. In addition, the $3.70 average price target… Continue Reading…
September 16, 2020
“MediWound Ltd. (MDWD)… To this end, DeGeeter rates MDWD an Outperform along with a $7 price target. Should his thesis play out, a potential twelve-month gain of 117% could be in the cards… UroGen Pharma (URGN)… To this end, Gershell… Continue Reading…
Recent Comments